$UNH | UnitedHealth Group Q3'24 Earnings Highlights:
πΉ Adjusted EPS: $7.15 (Est. $6.99) π’
πΉ Revenue: $100.82B (Est. $99.16B) π’; UP +9% YoY
πΉ Narrows FY24 Adj EPS Guidance to $27.50 - $27.75 (Previous: $27.50 - $28.00) π‘
πΉ Net Income: $6.06B
πΉ Earnings from Operations: $8.71B
πΈ Cash flows from operations were $14.0B
πΈ Return on Equity: 26.3% ππ» ππ»
Solid quarter with good growth and margins.
A powerful cash generating machine.
Very strong blue chip in a non-cyclical industry.
Supportive price action which just broke out of a 2 year consolidation.
Forward P/E of 21 not demanding, around the average for the last 3 years.
Buy and accumulate on market dips / bad news.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
